Keywords: Almirall, Ironwood, Forest Labs, Linaclotide, Irritable bowel sydrome, IBS

Almirall/Ironwood’s IBS drug linaclotide shows positive Ph III results

Article | 15 September 2010

Spain’s largest pharmaceutical company Almirall (ALM:MC) and USA-based partner Ironwood Pharmaceuticals (Nasdaq: IRWD) have announced positive top-line ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in